Amneal Pharmaceuticals, Inc.
アムニール製薬株式会社別名xxxxx別名
§01
基本情報
§02
サイト
§03
事業内容
Generic Research & Development
Complex Pharmaceutical Dosage Development
Regulatory Affairs
Portfolio and Project Management
Complex Generic Liquids
Nasal Sprays
Topicals
Transdermals
Ophthalmics
Inhalation
Specialty Pipeline
Clinical Development
Medical Affairs Operations
Biosimilars
Affordable Medicines (including retail generics, injectables and biosimilars)
Specialty (innovative branded pharmaceuticals focused on central nervous system and endocrine disord
AvKARE (distribution for the U.S. Federal government)
generics
injectables
biosimilars
specialty medicines
Retail generics
Injectables
Specialty medicines for Parkinson’s and endocrinology
CREXONT® (carbidopa and levodopa) extended-release capsules for Parkinson’s disease
Affordable Medicines (retail generics, injectables, biosimilars and international portfolios)
Specialty products
CREXONT
Brekiya® (dihydroergotamine mesylate) autoinjector
businessContentsName1
businessContentsName2
businessContentsName3
pharmaceuticals
Affordable Medicines segment
§04
関連会社
§05
関連図
ドラッグで移動 · クリックで詳細へ
§06
沿革
Launched in August 2017, the product is manufactured by a dedicated team working from our newly expanded Brookhaven, NY facility and distributed by our Glasgow, Kentucky team to pharmacies across the U.S. and Puerto Rico.![]()
It’s no surprise that the winter 2018 flu season was one of the worst on record. Daily news coverage about rising case numbers and increasing geographic incidence dominated headlines. As Americans undertook normally prescribed precautions to avoid the flu, our Amneal team was hard at working making sure those affected by the virus had the medicines they needed to fight back.![]()
§07
ニュース
ニュースはありません。
§09
出典・更新
DOMAIN単独ドメイン:あり
UPDATED2026-11-06 08:25 · Model: gpt-oss-20b(16)